In 2002, Indivior Incorporated received FDA approval for the buprenorphine medication Suboxone. The drug became a staple for medication-assisted treatment (MAT) of opioid use disorder (OUD).  However, a series of clinical studies and product liability lawsuits assert that Suboxone has the potential to cause serious dental complications, including tooth erosion and decay. Although extant medical […]

The post Studies Connect Suboxone Buprenorphine to Tooth Decay appeared first on Dolman Law Group.